FDA Committed To Third-Party Review, Henney Tells Senate HELP Committee
This article was originally published in The Gray Sheet
Executive Summary
FDA Commissioner Jane Henney is "puzzled" about the low utilization rate within the device industry of the agency's "Accredited Persons" third-party premarket review program, she said at an Oct. 21 Senate Health, Education, Labor and Pensions Committee hearing.